Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-07 Paulson Richard A. President and CEO Sale −2,542 $5.76 $15K 630,906
2022-06-03 Mason Michael EVP, CFO, Treasurer Sale −598 $6.04 $4K 138,512
2022-06-03 Mason Michael EVP, CFO, Treasurer Sale −3 $6.07 $18 138,509
2022-05-19 Schor Chen Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2022-05-19 PAKIANATHAN DEEPIKA Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2022-05-19 Oliger Christy J. Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2022-05-19 Mirza Mansoor Raza Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2022-05-19 Honig Peter Director Grant or award · Nonstatutory Stock Option (right to buy) +10,995 10,995
2022-05-19 BOHLIN GAREN G Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2022-05-19 Greene Barry E Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2022-05-04 Paulson Richard A. President and CEO Sale −633 $6.26 $4K 661,317
2022-05-04 Paulson Richard A. President and CEO Sale −27,869 $6.23 $174K 633,448
2022-04-29 Rangwala Reshma EVP & Chief Medical Officer Grant or award +65,000 65,000
2022-04-29 Rangwala Reshma EVP & Chief Medical Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2022-03-29 Shacham Sharon Chief Scientific Officer Grant or award +60,000 958,131
2022-03-29 Shacham Sharon Chief Scientific Officer Grant or award · Stock Option (right to buy) +90,000 90,000
2022-02-28 Frenkel Ran EVP, Chief Dev. Officer Grant or award +68,250 169,953
2022-02-28 Frenkel Ran EVP, Chief Dev. Officer Sale −1,663 $10.24 $17K 168,290
2022-02-28 Frenkel Ran EVP, Chief Dev. Officer Grant or award · Stock Option (right to buy) +90,000 90,000
2022-02-28 Mason Michael EVP, CFO & Treasurer Grant or award +88,200 141,508

Page 13 of 15 · 287 trades